Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
FRTX | Fresh Tracks Therapeutics, Inc. | CEO and CFO, Director | Dec 28, 2023 | |||
NEXI | NexImmune, Inc. | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney | Apr 5, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|